The IMCPL received a Current Good Manufacturing Practices (CGMP) award from the National Institutes of Health. Mission Deliver high-quality and safe translation of cutting-edge scientific breakthroughs into CGT therapies for improving human health. Capability & Services Research & Development Clinical Research & Activities Funding Leadership Car T Cell Therapy Cell Terapy Gene Therapy Success Stories Career Opportunities The IMCPL is western PA's largest Facility 15,000 Lab Space ft2 12 Clean Rooms 2 Locations Hillman & Pitt Tech Center News Landmark Study: Intracerebroventricular Bivalent CAR T Cells in Recurrent Glioblastoma Gene-Edited Islet Cell Transplant for Type 1 Diabetes
